Oppenheimer Holdings, Inc. (DE) (OPY): Price and Financial Metrics
OPY Stock Summary
- OPY's current price/earnings ratio is 4.07, which is higher than just 2.46% of US stocks with positive earnings.
- With a price/sales ratio of 0.42, Oppenheimer Holdings Inc has a higher such ratio than only 8.14% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Oppenheimer Holdings Inc is reporting a growth rate of 53.14%; that's higher than 81.36% of US stocks.
- Stocks that are quantitatively similar to OPY, based on their financial statements, market capitalization, and price volatility, are RVLV, HIBB, SCX, APT, and GNE.
- Visit OPY's SEC page to see the company's official filings. To visit the company's web site, go to www.oppenheimer.com.
OPY Stock Price Chart Interactive Chart >
OPY Price/Volume Stats
|Current price||$38.85||52-week high||$40.84|
|Prev. close||$39.52||52-week low||$14.21|
|Day high||$40.02||Avg. volume||130,374|
|50-day MA||$34.56||Dividend yield||1.21%|
|200-day MA||$27.01||Market Cap||485.35M|
Oppenheimer Holdings, Inc. (DE) (OPY) Company Bio
Oppenheimer Holdings provides a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions. The company was founded in 1881 and is based in New York, New York.
OPY Latest News Stream
|Loading, please wait...|
OPY Latest Social Stream
View Full OPY Social Stream
Latest OPY News From Around the Web
Below are the latest news stories about Oppenheimer Holdings Inc that investors may wish to consider to help them evaluate OPY as an investment opportunity.
Government of Canada supports initiative to address workplace sexual harassment and improve access to justice in Canada
OTTAWA, ON, March 3, 2021 /CNW/ - All individuals have the right to a safe workplace with fair treatment for all. Sexual harassment impacts the health and well-being of those involved, as well as their ability to perform their jobs to the best of their ability.
Oppenheimer Stick to Their Buy Rating for Community Health
Things escalated QUICKLY on Tuesday. Julius Malema, also miffed with Cyril Ramaphosa's links to Rupert and Oppenheimer, gave the president a stern warning.
Shares of coronavirus vaccine developer Inovio Pharmaceuticals Inc (NASDAQ: INO ) were surging Friday after a vote of confidence from the Street. Bullish Analyst, Fund Stake Prop Up Stock: Oppenheimer analyst Hartaj Singh initiated coverage of Inovio shares with an Outperform rating and $35 price target in a Thursday note. Although current mRNA vaccines have set a high efficacy bar in Phase 3 settings, INO-4800 has a differentiated profile, with a better safety and tolerability profile; longer shelf-life and easier storage; and potential flexibility to adjust for mutations and boosting, the analyst said. Inovio's deep expertise and decades-long history in DNA science, he said, could bring the company to the "finish line" soon, in a fashion similar to mRNA-based vaccines. Singh is also l...
Oppenheimer Holdings (OPY) had declared $0.12/share quarterly dividend, in line with previous.Payable Feb. 26; for shareholders of record Feb. 12; ex-div Feb. 11.See OPY Dividend Scorecard, Yield Chart, & Dividend Growth....
OPY Price Returns
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|
Continue Researching OPYWant to do more research on Oppenheimer Holdings Inc's stock and its price? Try the links below:
Oppenheimer Holdings Inc (OPY) Stock Price | Nasdaq
Oppenheimer Holdings Inc (OPY) Stock Quote, History and News - Yahoo Finance
Oppenheimer Holdings Inc (OPY) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!